Role of vericiguat in management of patients with heart failure with reduced ejection fraction after worsening episode

Abstract Worsening heart failure (HF) is a vulnerable period in which the patient has a markedly high risk of death or HF hospitalization (up to 10% and 30%, respectively, within the first weeks after episode). The prognosis of HF patients can be improved through a comprehensive approach that consid...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Aleix Olivella, Luis Almenar‐Bonet, Pedro Moliner, Emmanuel Coloma, Antoni Martínez‐Rubio, Marco Paz Bermejo, Ramon Boixeda, German Cediel, Ana Belén Méndez Fernández, Lorenzo Facila Rubio
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	Oxford University Press 2024-04-01
סדרה:	ESC Heart Failure
נושאים:	Heart failure Sacubitril–valsartan SGLT2 Vericiguat Worsening
גישה מקוונת:	https://doi.org/10.1002/ehf2.14647
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!